GW Resident Segment – January 2018 Edition with Dr. Hsu
In this throwback edition of the JDD Podcast "Ask the Investigator," host Adam Friedman speaks with Dr. Sylvia Hsu, Professor and Chair of Dermatology at the Lewis Katz School of Medicine at Temple University on her study published in the August 2008 edition of the JDD entitled, "A Case Series of 48 Patients Treated with Thalidomide." Get a taste of rich dermatology history with the evolution of t …
Continue reading "GW Resident Segment – January 2018 Edition with Dr. Hsu"
Human fibroblasts are a versatile source of optimal growth factors that provide approaches to repair skin in Upregulation of Extracellular Matrix Genes Corroborates Clinical Efficacy of Human Fibroblast-Derived Growth Factors in Skin Rejuvenation
By working from a CD8+ T cell line, it should be possible to identify and patent products capable of treating infectious diseases, antigen- … 
Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis.
Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study READ NOW
The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps … 
Go superpotent or go home. The utility and safety of Class 1 topical steroids.
Dr. Tina Bhutani and Dr. Adam Friedman
In this edition of the JDD Podcast, Ask the Investigator, host Dr. Adam Friedman digs deep with UCSF Assistant Professor of Dermatology Dr. Tina Bhutani to powerlift the most up to date safety data on Class 1 superpotent topical steroids from her study entitled "Update on the … 